Production (Stage)
Surgery Partners, Inc.
SGRY
$22.80
$0.200.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.17B | 3.11B | 2.99B | 2.89B | 2.79B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.17B | 3.11B | 2.99B | 2.89B | 2.79B |
| Cost of Revenue | 2.42B | 2.37B | 2.28B | 2.20B | 2.13B |
| Gross Profit | 752.20M | 745.60M | 705.60M | 693.90M | 668.80M |
| SG&A Expenses | 141.50M | 138.70M | 123.60M | 131.20M | 122.10M |
| Depreciation & Amortization | 155.20M | 152.60M | 149.80M | 128.50M | 118.10M |
| Other Operating Expenses | -18.00M | -20.00M | -15.00M | -14.00M | -8.70M |
| Total Operating Expenses | 2.70B | 2.64B | 2.54B | 2.44B | 2.36B |
| Operating Income | 473.50M | 474.30M | 447.20M | 448.20M | 437.30M |
| Income Before Tax | 118.10M | 147.10M | 125.60M | 147.50M | 164.10M |
| Income Tax Expenses | 130.20M | 134.60M | 19.80M | 18.40M | 5.70M |
| Earnings from Continuing Operations | -12.10 | 12.50 | 105.80 | 129.10 | 158.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -181.30M | -180.60M | -166.40M | -162.90M | -157.80M |
| Net Income | -193.40M | -168.10M | -60.60M | -33.80M | 600.00K |
| EBIT | 473.50M | 474.30M | 447.20M | 448.20M | 437.30M |
| EBITDA | 628.70M | 626.90M | 597.00M | 576.70M | 555.40M |
| EPS Basic | -1.53 | -1.33 | -0.48 | -0.27 | 0.00 |
| Normalized Basic EPS | -0.05 | 0.02 | 0.00 | 0.03 | 0.02 |
| EPS Diluted | -1.53 | -1.33 | -0.48 | -0.27 | 0.00 |
| Normalized Diluted EPS | -0.05 | 0.02 | 0.00 | 0.03 | 0.03 |
| Average Basic Shares Outstanding | 505.12M | 504.49M | 504.05M | 503.63M | 503.21M |
| Average Diluted Shares Outstanding | 505.12M | 504.49M | 504.05M | 503.63M | 504.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |